R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_value Arg1:T3 Arg2:T4	
R3	AND Arg1:T2 Arg2:T3	
R4	Has_qualifier Arg1:T5 Arg2:T6	
R5	AND Arg1:T8 Arg2:T7	
R6	Has_value Arg1:T7 Arg2:T9	
*	OR T8 T11 T13 T10
R7	Has_value Arg1:T14 Arg2:T15	
R8	AND Arg1:T13 Arg2:T14	
R9	Subsumes Arg1:T6 Arg2:T8	
R10	Has_value Arg1:T16 Arg2:T17	
R11	Has_value Arg1:T18 Arg2:T19	
R12	Has_value Arg1:T20 Arg2:T21	
R13	Has_value Arg1:T22 Arg2:T23	
R14	Has_value Arg1:T24 Arg2:T25	
R15	Has_value Arg1:T26 Arg2:T27	
R16	Has_value Arg1:T28 Arg2:T29	
*	OR T24 T26 T28
R17	Subsumes Arg1:T23 Arg2:T24	
R18	Has_value Arg1:T31 Arg2:T32	
R19	Has_value Arg1:T33 Arg2:T34	
R20	Subsumes Arg1:T32 Arg2:T33	
R21	Has_value Arg1:T35 Arg2:T36	
R22	Has_value Arg1:T37 Arg2:T38	
R24	Has_value Arg1:T39 Arg2:T40	
R25	AND Arg1:T37 Arg2:T39	
R26	Subsumes Arg1:T36 Arg2:T37	
R27	Has_negation Arg1:T45 Arg2:T47	
R28	Has_temporal Arg1:T45 Arg2:T46	
R29	Has_temporal Arg1:T48 Arg2:T49	
R30	Has_temporal Arg1:T48 Arg2:T50	
*	OR T53 T54 T55
R32	Has_temporal Arg1:T51 Arg2:T52	
R33	AND Arg1:T51 Arg2:T53	
R34	Has_negation Arg1:T51 Arg2:T56	
R35	Has_temporal Arg1:T57 Arg2:T58	
R36	Has_temporal Arg1:T57 Arg2:T60	
R37	Has_negation Arg1:T57 Arg2:T59	
R31	Has_index Arg1:T50 Arg2:T61	
R38	Has_negation Arg1:T48 Arg2:T62	
R39	AND Arg1:T45 Arg2:T48	
R40	Has_index Arg1:T58 Arg2:T64	
R23	Has_value Arg1:T41 Arg2:T42	
*	OR T40 T41
T1	Condition 35 60	adenocarcinoma of stomach
T2	Qualifier 22 34	unresectable
T3	Measurement 0 14	Pathologically
T4	Value 15 21	proven
T5	Condition 96 103	disease
T6	Qualifier 67 95	uni-dimensionally measurable
T7	Measurement 114 130	longest diameter
T8	Procedure 139 159	conventional CT scan
T9	Value 105 113;131 135	at least 2 cm
T10	Procedure 161 166	x-ray
T11	Procedure 170 190	physical examination
T13	Procedure 202 216	spiral CT scan
T14	Measurement 114 130	longest diameter
T15	Value 105 113;195 198	at least 1cm
T16	Person 219 222	Age
T17	Value 223 241	18 to 70 years old
T18	Measurement 243 268	Estimated life expectancy
T19	Value 272 290	more than 3 months
T20	Measurement 292 315	ECOG performance status
T21	Value 319 329	2 or lower
T22	Measurement 340 360	bone marrow function
T23	Value 331 339	Adequate
T24	Measurement 361 392	absolute neutrophil count [ANC]
T25	Value 393 402	≥1,500/µL
T26	Measurement 404 414	hemoglobin
T27	Value 415 424	≥9.0 g/dL
T28	Measurement 429 438	platelets
T29	Value 439 450	≥100,000/µL
T31	Measurement 462 477	kidney function
T32	Value 453 461	Adequate
T33	Measurement 479 495	serum creatinine
T34	Value 496 507	< 1.5 mg/dL
T35	Measurement 519 533	liver function
T36	Value 510 518	Adequate
T37	Measurement 535 556	serum total bilirubin
T38	Value 557 595	< 2 times the upper normal limit (UNL)
T39	Measurement 597 623	serum transaminases levels
T40	Value 624 632;679 682	<3 times UNL
T41	Condition 661 677	liver metastasis
T42	Value 634 642;679 682	<5 times UNL
T45	Procedure 694 706	chemotherapy
T46	Temporal 688 693	prior
T47	Negation 685 687	No
T48	Procedure 717 738	adjuvant chemotherapy
T49	Temporal 711 716	prior
T50	Temporal 748 783	at least 6 months before enrollment
T51	Procedure 809 830	adjuvant chemotherapy
T52	Temporal 803 808	prior
T53	Drug 836 848	capecitabine
T54	Drug 852 855	S-1
T55	Drug 859 881	camptothecin analogues
T56	Negation 886 894	excluded
T57	Procedure 906 923	radiation therapy
T58	Temporal 928 962	at least 4 weeks before enrollment
T59	Negation 897 899	No
T60	Temporal 900 905	prior
T61	Reference_point 773 783	enrollment
T62	Negation 784 795	was allowed
T64	Reference_point 952 962	enrollment
